Overview
ProBioGen AG is a Berlin-based CDMO specializing in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals including proteins, antibodies, viral vectors, and vaccines. They offer proprietary technologies like GlymaxX® for afucosylated antibodies enhancing ADCC efficacy. Services are supported by a GMP-compliant quality system meeting EMA/FDA standards with up to 1000L bioreactor capacity.
Frequently asked questions
- What CDMO services does ProBioGen provide?
- Cell line engineering with media optimization, upstream/downstream process development, GMP and non-GMP manufacturing of proteins, antibodies, viral vectors, and vaccines, plus analytical services including cell-based bioassays.
- What regulatory standards does ProBioGen comply with?
- All services follow international ISO and GMP standards compliant with EMA/FDA requirements, embedded in a total quality management system.
- Where is ProBioGen located and what are their manufacturing capabilities?
- Based in Berlin, Germany, with 30+ years experience; offers scalable GMP manufacturing up to 1000L bioreactors for biopharmaceuticals.